Table 1.
Clinical and laboratory characteristics of patients at diagnosis
| Patient no. | Sex/Age, yr | Initial clinical presentation | Lymph node | Skin | BM | Other sites | PB | WBC, × 103/L | Hb, g/dL | PLT, × 109/L | LDH, IU/L | Albumin, g/dL | Creatinine, mg/dL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #1 | M/67 | Solitary macule of the back | No | Presence | No | 9,860 | 10.6 | 149 | 426 (N) | 4.5 | 1.1 | ||
| #2 | F/40 | Solitary mass of the breast | Multiple LAP | Presence | No | 5,970 | 12.8 | 231 | 1,500 (Inc) | 3.7 | 0.4 | ||
| #3 | M/41 | Solitary mass of the tibia | No | Presence | No | 5,000 | 16.3 | 222 | 333 (N) | 4.6 | 0.9 | ||
| #4 | M/79 | Solitary macule of the foot | No | Presence | Presence (blast 72%) | Liver, spleen | Blast 45% | 39,400 | 8.4 | 76 | 611 (Inc) | 4.2 | 0.9 |
| #5 | M/79 | Solitary nodule of the back | Multiple LAP | Presence | No | 8,740 | 11.6 | 221 | 442 (N) | 4.5 | 0.9 | ||
| #6 | F/31 | Solitary macule of the face | No | Presence | No | 5,880 | 12.2 | 319 | 339 (N) | 4.2 | 0.4 | ||
| #7 | M/18 | Multifocal nodule of the face | Multiple LAP | Presence | Presence (blast 85%) | Nasal cavity Liver, spleen | Atypical lymphocyte 35% | 11,100 | 14.3 | 74 | 2,072 (Inc) | 4.4 | 1.2 |
| #8 | M/52 | Multifocal macule of the face | Multiple LAP | Presence | Presence (blast 76%) | Blast 45% | 6,600 | 12.3 | 148 | 512 (Inc) | 4.1 | 1.1 | |
| #9 | M/31 | Multifocal periorbital mass | No | Presence | No | Soft tissue | 5,160 | 16 | 158 | 480 (Inc) | 4.5 | 1.2 | |
| #10 | F/33 | Multifocal skin nodules | Multiple LAP | Presence | No | 8,900 | 10 | 283 | 450 (N) | 3.2 | 0.6 |
BM, bone marrow; PB, peripheral blood; WBC, white blood cell; Hb, hemoglobin; PLT, platelet; LDH, lactate dehydrogenase; N, number; LAP, lymphadenopathy; Inc, increased.